Analysts/Institutional Investor Meet/Con. Call Updates

August 10, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Intimation of participation in the Investor Conferences Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the management/officials of the Company will be participating in the following Investor Conferences, being organized and scheduled by the entities as indicated: Date Name of Event City Meeting Type One-on-One / August 13, 2026 Emkay Confluence Mumbai Group Meeting One-on-One / August 13, 2026 Equirus Annual India Conference’26 Mumbai Group Meeting Motilal Oswal 22nd Annual Global One-on-One / August 17, 2026 Mumbai Investor Conference, 2026 Group Meeting During the meeting with investors/analysts no unpublished price sensitive information (“UPSI”) shall be disclosed which is not already available in public domain. The discussion would be based on the general business outlook and information which is already in public domain. The schedule of the above mentioned Investor Conferences is subject to change due to exigencies on either side. The intimation of participation in the Investor Conferences is also being uploaded on the website of the company i.e. www.mankindpharma.com. This is for your information and records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer